Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

STAT3-IN-B9 (Synonyms: STAT3 IN B9, B9)

Catalog No. T28865 Copy Product Info
Purity: 98.19%
😃Good
STAT3-IN-B9 (B9) is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.

STAT3-IN-B9

Copy Product Info
😃Good
Catalog No. T28865
Synonyms STAT3 IN B9, B9

STAT3-IN-B9 (B9) is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.

STAT3-IN-B9
Cas No. 825611-06-1
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$117In StockIn Stock
2 mg$165In StockIn Stock
5 mg$262In StockIn Stock
10 mg$388In StockIn Stock
25 mg$592In StockIn Stock
50 mg$828In StockIn Stock
100 mg$1,110In StockIn Stock
200 mg$1,480In StockIn Stock
1 mL x 10 mM (in DMSO)$283In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.19%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

STAT3-IN-B9 AI Summary
STAT3-IN-B9 exhibits binding affinity to various STAT3 mutants as well as wild-type STAT3. It demonstrates antiproliferative activity against several cancer cell lines harboring active STAT3, with varying IC50 values, indicating its potential as an inhibitor of cell growth. Additionally, the compound inhibits STAT3-dependent transcriptional activity in HeLa cells, suggesting a role in modulating gene expression mediated by STAT3. The selectivity ratio of the compound for a specific STAT3 mutant compared to wild-type STAT3 indicates its potential selectivity towards different STAT3 variants..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
STAT3-IN-B9 (B9) is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.
SynonymsSTAT3 IN B9, B9
Chemical Properties
Molecular Weight379.39
FormulaC20H13NO5S
Cas No.825611-06-1
SmilesO=C1C=2C(C(=O)C=3C1=CC=CC3)=CC=C(S(NC4=CC=C(O)C=C4)(=O)=O)C2
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 4.8 mg/mL (12.65 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6358 mL13.1791 mL26.3581 mL131.7905 mL
5 mM0.5272 mL2.6358 mL5.2716 mL26.3581 mL
10 mM0.2636 mL1.3179 mL2.6358 mL13.1791 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy STAT3-IN-B9 | purchase STAT3-IN-B9 | STAT3-IN-B9 cost | order STAT3-IN-B9 | STAT3-IN-B9 chemical structure | STAT3-IN-B9 formula | STAT3-IN-B9 molecular weight